The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York 2026 FDA Peptide Reclassification Purefico Medspa and Therapy Decoded with Dr Andrius: BPC 157 and Tendon Injuries Roam Regeneration or Risk? A Narrative Review of BPC 157 for Musculoskeletal Healing Current Reviews in Musculoskeletal Medicine Springer Nature Link Everything You Need to Know About the FDA Peptide Ban